Stock Groups

Fourth COVID vaccine shot sharply raises serious illness resistance for over 60s: Israel -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – A man is given the fourth dose coronavirus (COVID-19 vaccine) after Israel has approved another booster shot for immunocompromised people older than 60 and staff in Tel Aviv. This was on January 3, 2022. REUTERS/Amir Cohen

JERUSALEM (Reuters] – The fourth dose of COVID-19 vaccine administered to over-60s in Israel has made them three times less likely to contract serious illness than thrice-vaccinated persons in the age group.

According to the ministry, the second booster (or fourth dose) doubled the resistance of those who had received three doses. The fourth dose of Pfizer/BioNtech vaccine was offered to over-60s earlier in the month.

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]